“If we don’t speak up, they will not hear!” We were very honoured and grateful to present our CutCancer Project and our research done at NIB (National Institute of Biology), at Research & Innovation Transforming European Healthcare in Brussels, that was so greatly organized by Slovenian Business & Research Association (SBRA) Prof. Dr. Drasko Veselinovic…
Read article
The National Institute of Biology was proud to host Michael John Burgum, PhD, a researcher from Swan – Swansea University – UK. The purpose of the visit to NIB was to acquire the theoretical and practical knowledge of HepG2 liver spheroid tissue culture using Bioreactors over a 21-day period. Given the time to culture…
Read article
Tumours are complex mixture of a heterogeneous population of cells that possess distinct genetic, morphological, and phenotypic profiles, which can affect tumour development and therapeutic resistance. The success of cancer treatments relies on the comprehension of the heterogeneous and immune hostile tumour microenvironment (TME), further on providing additional possibilities to eliminate its tumour supportive role.…
Read article
Dr. Van Maldegem from VUmc is one of the pioneers in using and developing Imaging Mass Cytometry (IMC) method for cancer research. IMC enables detailed and contextual characterisation of protein expression and is a mass spectrometry-based technique that allows for the immunostaining of up to 40 markers in a single tissue section. Tissue sections of primary…
Read article
International Conference on Pathology of the Victor Babeș Institute took place at the the Institute, Splaiul Independeței 99-101, Bucharest, between November 2-4, 2022. The conference covered topis of cellular and molecular pathology, immunology, omics, neuroscience and cardiovascular pathology. Barbara Breznik has been invited to give a talk “Personalized tumor models reveal mechanisms of glioblastoma immunosuppressive…
Read article
We visited Karolinska Institutet and Lewensohn/Viktorsson team and their research facility on a sunny October day. Metka and Barbara presented CutCancer project and their research on “Personalized glioblastoma model for standard and immuno-therapy research” at translational lunch seminar that was open for researchers and medical doctors. Glioblastoma remains a lethal disease despite current standard treatment…
Read article
Martina Štampar, PhD, gave an oral presentation entitled “Hepatic 3D Cell Model – A Sensitive Approach for Determining the Adverse (Geno)toxic Activity of Air Pollutants.” She summarized research work on benzo[a]pyrene (B[a]P), which is the main representative of polycyclic aromatic hydrocarbons (PAHs) as well as a ubiquitous environmental pollutant found in air, surface water, soil,…
Read article
We are always investing in the product of research, but we have to invest also in the future researchers themselves. NIB (National Institute of Biology) opened the door to more than 550 young students to give them better understanding of the world they live in. We also presented our CutCancer Project to give them better…
Read article
On World Cancer Research Day, the National Institute of Biology hosted a lecture and a discussion about new technologies that will increase the understanding of cancer as part of the CutCancer project and thus open up new therapeutic options. As part of the prestigious EU project – Horizon Europe Twining, the NIB researchers presented the…
Read articleBlagoj Mukaetov1, 2, 3, Manca Osolin1, Nika Banovšek1, Bernarda Majc1, Anamarija Habič1,4, Metka Novak1, Tamara Lah Turnšek1, Barbara Breznik1 & Laurent Devel3 1National Institute of Biology, Department of Genetic Toxicology and Cancer Biology, 111 Večna pot, 1000 Ljubljana, Slovenia 2Faculty of Chemistry and Chemical Technology, University of Ljubljana, 113 Večna pot, 1000 Ljubljana, Slovenia 3Université Paris-Saclay,…
Read article